HRT Financial’s Beam Therapeutics BEAM Stock Holding History

HRT Financial’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-219,426	Closed	-$5.23M	–	4205
2026 Q1	$5.23M	Buy	219,426 +68,243	+45%	+$1.89M	0.01%	973
2025 Q4	$4.19M	Sell	151,183 -11,528	-7%	-$294K	0.01%	865
2025 Q3	$3.95M	Buy	+162,711	New	+$3.24M	0.01%	791
2025 Q1	–	Sell	-26,177	Closed	-$649K	–	2537
2024 Q4	$649K	Buy	+26,177	New	+$668K	﹤0.01%	1312
2024 Q2	–	Sell	-37,955	Closed	-$1.25M	–	2224
2024 Q1	$1.25M	Buy	37,955 +27,974	+280%	+$872K	0.01%	779
2023 Q4	$271K	Buy	+9,981	New	+$248K	﹤0.01%	1658
2022 Q2	–	Sell	-20,846	Closed	-$1.19M	–	2938
2022 Q1	$1.19M	Buy	+20,846	New	+$1.37M	0.01%	911
2021 Q3	–	Sell	-1,827	Closed	-$235K	–	3280
2021 Q2	$235K	Sell	1,827 -6,394	-78%	-$509K	﹤0.01%	2299
2021 Q1	$658K	Buy	+8,221	New	+$782K	0.01%	1566

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

HRT Financial's BEAM Position: Q2 2026 in Review

HRT Financial sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 219,426 shares — an estimated $5.23M sold.

HRT Financial first reported a position in BEAM in Q1 2021 and held it in 9 quarters. The position peaked at $5.23M in Q1 2026. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

HRT Financial reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 219,426 Beam Therapeutics shares in Q2 2026, an estimated $5.23M.
HRT Financial first reported a position in Beam Therapeutics in Q1 2021 and held it in 9 quarters.
HRT Financial's Beam Therapeutics position peaked at $5.23M in Q1 2026.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.